Mevacor OTC opinions
This article was originally published in The Tan Sheet
Executive Summary
American Pharmacists Association supports a "strong role" for pharmacists if an Rx-to-OTC switch of lovastatin 20 mg were to be approved, former APhA President Janet Engle says Jan. 14. An APhA task force developed the "pharmacy care OTC" category for drugs to treat chronic, asymptomatic conditions last fall (1"The Tan Sheet" Nov. 8, 2004, p. 10). J&J/Merck says OTC Mevacor should be sold only in retail outlets with a pharmacy. FDA's Nonprescription Drugs and Endocrinologic & Metabolic Drugs advisory committees voted 20-3 against the switch...
You may also be interested in...
“Pharmacy Care” OTC Category Considered By APhA Task Force
A new category of "pharmacy care" drugs could broaden access to certain over-the-counter drugs, according to the American Pharmacists Association
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.